Back to search
Lymphocytic Colitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lymphocytic Colitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Lymphocytic Colitis trials you may qualify forThis is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following e…
Patients will receive budesonide or placebo for the treatment of active lymphocytic colitis. This study includes stool collections, blood draws, weekly question…
This research trial studies the mechanisms of idelalisib-associated diarrhea in patients with chronic lymphocytic leukemia, indolent non-hodgkin lymphoma, or sm…
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of lymphocytic colitis.
The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.
The purpose of this study is to determine whether chromoendoscopy using Indigo-Carmine dye spray is useful in diagnosing microscopic colitis among patients unde…
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis